Table 2.
First Look study: antenatal and obstetric care by treatment group
Intervention | Control | RR (95% CI) | P-value | |
---|---|---|---|---|
All women, N | 24 008 | 22 896 | ||
Antenatal care utilisation, n/N (%) | ||||
Antenatal care utilisation ≥4 visits, n (%) | 12 021 (50.1) | 10 866 (47.5) | 1.03 (0.90, 1.17) | 0.6376* |
Delivery location, n (%) | ||||
Hospital, any | 8580 (35.8) | 7768 (33.9) | 0.4261** | |
Clinic, any | 7936 (33.1) | 7966 (34.8) | ||
Home/Other | 7483 (31.2) | 7152 (31.3) | ||
Delivery at facility with CS, n/N (%) | 8098 (33.7) | 7289 (31.8) | 1.04 (0.86, 1.26) | |
Delivery mode, n (%) | 0.4280** | |||
CS | 2919 (12.2) | 2808 (12.3) | ||
Assisted (forceps) | 45 (0.2) | 31 (0.1) | ||
Vaginal | 20 998 (87.6) | 20 015 (87.6) | ||
Complicated deliveries | ||||
Complicated deliveries, n/N (%) | 6152/24 008 (25.6) | 5528/22 896 (24.1) | 1.10 (1.02, 1.18)*** | |
ANC ≥ 4 visits | 2986 (50.8) | 2661 (50.7) | 1.00 (0.88, 1.12)*** | |
Delivery location, n (%) | ||||
Hospital, any | 2682 (45.6) | 2404 (45.8) | 0.1694 | |
Clinic, any | 1433 (24.4) | 1247 (23.7) | ||
Home/Other | 1766 (30.0) | 1602 (30.5) | ||
Delivered in a hospital with CS, n/N (%) | 2569/6152 (41.8) | 2252/5528 (40.7) | 1.03 (0.89, 1.20)*** | 0.6841**** |
Delivery mode, n (%) | ||||
CS | 1199 (19.5) | 1204 (21.8) | 0 9747**** | |
Assisted (forceps or vacuum) | 17 (0.3) | 14 (0.3) | ||
Vaginal | 4933 (80.2) | 4307 (78.0) |
CS, caesarean section capabilities.
P-value from a t test described by Gail
P-value from a generalised logit model adjusting for treatment and strata with generalised estimating equations
Relative risks from a log-binomial model adjusting for treatment and strata with generalised estimating equations to control for cluster-level effects.
P-value from a log-binomial model adjusting for treatment and strata with generalised estimating equations to control for cluster-level effects.